Submitted abstracts should include unpublished data.
The final decisions will be made by representatives from LMHI. Corresponding authors will be informed of the decision by February 15, 2021.
The Scientific Committee and associated reviewer teams will review and score submissions. Abstracts will be selected on the basis of their medical and scientific significance, timeliness, quality of data and methodology, adherence to specific format requirements, and other criteria described herein.
You will be notified as whether your abstract has been accepted until February 15, 2021. Full details, including the timing of your presentations will be notified to accepted presenters at that time.
Please note that detailed individual feedback on submissions will not be issued. The time duration allocated to presenters will be made available to successful candidates on confirmation of the acceptance of their abstracts.
In order for an abstract to be considered for poster or oral presentation, the presenting author must be registered and paid by March 8, 2021. Any abstract whose presenting author is not registered will not be considered for poster or oral presentation.
For more information, please contact the Organization Secretariat at [email protected]